small molecule program targeting Tregs (Tempero)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namesmall molecule program targeting Tregs (Tempero)
Drug Alias Namenext-generation therapy enhancing Tregs (Tempero)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunomodulatorsT lymphocytes stimulants
TargetsUpdating
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTempero Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTempero Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsAutoimmune Diseases

Other Information

ATC CodeN/A
Related LinksN/A